Arcadia Biosciences Announces Date of First Quarter 2020 Financial Results and Business Highlights Conference Call
Get Alerts RKDA Hot Sheet
Join SI Premium – FREE
DAVIS, Calif., May 6, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today announced that it will release its financial and business results for the first quarter of 2020 after market close on May 13, 2020.
The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and the year's key strategic achievements. Interested participants can join the conference call using the following numbers:
U.S. Toll-Free Dial-In: | +1-844-243-4690 |
International Dial-In: | +1-225-283-0138 |
Passcode: | 3560919 |
A live webcast of the conference call will be available on the Investors section of Arcadia's website at www.arcadiabio.com. Following completion of the call, a recorded replay will be available on the company's investor website.
About Arcadia Biosciences, Inc.Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company's GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Arcadia's agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. The company's new GoodHemp™ seed catalog delivers genetically superior hemp seeds, clones, transplants, flower and extracts, applying the company's proprietary crop innovation technology, ArcaTech, to an emerging crop. For more information, visit www.arcadiabio.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-announces-date-of-first-quarter-2020-financial-results-and-business-highlights-conference-call-301053680.html
SOURCE Arcadia Biosciences
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uxin Reports Unaudited Third Quarter of Fiscal Year 2024 Financial Results
- PolyU forms global partnership with ZEISS Vision Care to expand impact and accelerate market penetration of patented myopia control technology
- Bitrue Report Uncovers Potential of Decentralized GPU Rental Market to Disrupt Big Tech's Grip on AI Resources
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!